Chemomab Therapeutics CEO Dr Adi Mor discusses Q3 results; progress with lead PSC treatment

By Proactive Investors / November 14, 2024 / www.youtube.com / Article Link


Chemomab Therapeutics Ltd (NASDAQ:CMMB) CEO Dr Adi Mor talked with Proactive's Stephen Gunnion about recent ...

Recent News

Geopolitical risk outlook unclear after US election
January 06, 2025 / www.canadianminingreport.com

Low valuations offer a cushion to mining sector
January 06, 2025 / www.canadianminingreport.com

Polarized gold and iron ore moves, moderate aluminum and copper gains
December 30, 2024 / www.canadianminingreport.com

Large TSXV stocks strong on company specific drivers
December 30, 2024 / www.canadianminingreport.com

Canadian political turmoil with Trump trade policy the catalyst
December 23, 2024 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok